Disposable Syringes Market

Market Overview

The global disposable syringes market size was valued at USD 6291.42 million in 2022. It is estimated to reach USD 9676.75 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Factors such as Rising Prevalence of Needlestick Injuries and Favorable Government Initiatives, significantly drives the disposable syringes market demand by 2031.

Disposable syringes are medical instruments that are discarded after one-time use. These instruments are hollow cylinders that work on a piston mechanism. These are plastic syringes for medicine, veterinary medicine, and research and development (R&D). In addition, disposable syringes are used to collect blood samples from a patient. They are less expensive than conventional syringes and require no maintenance. Disposable syringes help to preserve patient safety while lowering the possibility of cross-contamination.

Disposable syringes are frequently used to administer medications intravenously or intramuscularly to treat various disorders. Moreover, these devices are also employed in delivering various therapeutic drugs into a patient's body. Also, different types of syringes, such as conventional and safety disposable syringes, are available in the market. The safety disposable syringes offer various benefits over conventional syringes, such as protecting against needlestick injuries.

Highlights

• Safety disposable syringes dominatetheproducttype segment
• Therapeutic injections dominate the application segment
• North Americais the highest shareholder in the global market

Market Dynamics

Global Disposable Syringes Market Drivers:

Rising Prevalence of Needlestick Injuries

The rise in needlestick injury cases across the globe is the primary factor that boosts the market's growth. Needlestick injuries are responsible for spreading fatal contagious infections from a patient to the healthcare workers such as doctors and nurses. Infections that spread due to needlestick injuries include hepatitis B, hepatitis C, HIV, and other blood-borne infections. For example, the Occupational Safety and Health Administration (OSHA) estimates that needlestick injuries affect around 5.6 million people annually globally. Moreover, about 384,000 healthcare personnel yearly suffer from needlestick injuries in the U.S. Therefore, medical professionals prefer safety syringes to prevent cross-infection. Therefore, the rise in incidences of needlestick injuries has a significant impact on the disposable syringes market.

Favorable Government Initiatives

Active government initiatives and continuous efforts to ensure safer injection practices boost the global safety syringes disposable syringes market growth. For instance, the occupational safety and health administration (OSHA), an agency in the U.S., assures safe and healthy working conditions for working women and men. This organization works toward ensuring healthcare safety practices and encourages using disposable syringes to avoid infections.

Additionally, OSHA recommends safety needle syringes as one of the possible solutions to prevent needlestick injuries. Similarly, the world health organization (WHO) launched a new policy in 2015 to eradicate the practice of unsafe injections globally. In addition, in 2010, the regulation Council Directive 2010/32/EU, 3020/32/EU implemented regulations on preventing sharp injuries, including needlestick injuries (NSIs), across hospitals and healthcare sectors in Europe. Therefore, this has led to a surge in adopting safety disposable syringes across hospitals and ambulatory surgical centers.

Global Disposable Syringes Market Restraint:

High Cost of Safety Disposable Syringes

The high cost of safety disposable syringes has limited their adoption across small hospitals and clinics in emerging economies. The cost of these syringes, especially retractable safety syringes, is considerably higher than conventional syringes without safety features. Moreover, safety disposable syringes embedded with the automated mode of retraction mechanism are extremely expensive. Other syringes with advanced features, such as single-handed technique, are costly. Thus, the high price of safety disposable syringes hinders the growth of the disposable syringes industry.

Global Disposable Syringes Market Opportunities:

High Growth Potential in Developing Economies

Developing economies offer lucrative opportunities for disposable syringe providers to expand their business. The constantly evolving life science industry drives the market's growth in developing economies such as India and China. In addition, the surge in healthcare expenditure across the globe is another factor contributing to this market's growth. Moreover, the progress of the healthcare sector in developing economies is expected to supplement the market growth. Further, developing countries in Asia-Pacific and LAMEA pose a high market potential due to the large patient base of chronic conditions such as diabetes. Therefore, the abovementioned factors are expected to provide numerous opportunities for market growth in developing nations.

Regional Analysis

Based on region, the global disposable syringes market share is segmented into North America, Europe, Asia-Pacific, and LAMEA.

North America Dominates the Global Market

North America is the most significant shareholder in the global disposable syringes market and is projected to grow at a CAGR of 4.3% during the forecast period. The North American disposable syringe market accounted for the largest share owing to stringent government regulations related to the use of safety disposable syringes and favorable reimbursement policies related to healthcare. The factors that further boost the growth of this market include the easy availability of disposable syringes and the presence of a large number of operating rooms and research laboratories where disposable syringes are commonly used. Moreover, the region's key players, such as Becton, Dickinson and Company, Cardinal Health, and Johnson & Johnson, contribute toward the market's growth.

Another significant element driving the market expansion is the rise in the frequency of needlestick injuries in the area. For instance, according to the Occupational Safety and Health Administration (OSHA), hospital-based healthcare personnel sustain approximately 384,000 needlestick injuries annually in the U.S. Moreover, by including other non-acute healthcare facilities, yearly needlestick injuries are estimated to reach 600,000. Therefore, the rise in needlestick injuries in the region has propelled the demand for safety syringes. Furthermore, the rise in the prevalence of diabetes in the region is a significant factor that boosts the market's growth. For instance, approximately 1.25 million people in America have type 1 diabetes, and it is projected to reach 5 million by 2050. Thus, the alarming increase in the prevalence of diabetes has led to the use of insulin administered into the subcutaneous fat with the help of disposable safety syringes.

Asia-Pacific is projected to grow at a CAGR of 6.3% over the forecast period. This region offers lucrative opportunities for the disposable syringes market and is anticipated to register the highest growth rate during the forecast period. In addition, an increase in vaccination programs by the WHO, UNICEF, and Red Cross; improvement in health standards; and a rise in disposable income are the significant factors that drive the growth of the disposable syringes industry in Asia-Pacific. China is the major contributor in the Asia-Pacific region and contributes significantly toward the market's growth. Furthermore, an increase in healthcare expenditure in the medical field is anticipated to fuel the market growth during the forecast period. In addition, the surge in the prevalence of various lethal infections such as hepatitis C, hepatitis B, and HIV and the need to prevent cross-infections lead to the demand for safety disposable syringes in the region. For instance, according to the latest estimates by the WHO, 40 million people are infected with hepatitis B, and approximately 6–12 million people are infected by hepatitis C in India.

Europe is one of the lucrative markets for safety syringes, owing to key players such as B. Braun Melsungen AG, Novo Nordisk A/S, and Henke-Sass Wolf, pioneers in innovation, design, and manufacture of disposable syringes. This results in the easy availability of these devices in the region. Furthermore, the rise in needlestick injuries in the region is another major factor that fuels the demand for safety syringes. For instance, according to the European Parliament, more than one million needlestick injuries are reported every year in Europe.

Furthermore, the surge in awareness related to damage caused by needlestick injuries propels the growth of this market. During venipuncture, injection administration, operation, aspiration, handling clinical waste, and cleaning work areas, the medical staff and patients are at high risk of suffering from needlestick injuries. These injuries transmit lethal diseases such as hepatitis B, hepatitis C, and HIV. This prompted the creation of governmental guidelines, such as the European Union's directive established in May 2010 to minimize injuries and blood-borne illnesses in hospitals and among healthcare workers caused by sharp objects like needles. Such governmental instructions significantly boost the demand for safety disposable syringes with a built-in safety mechanism. This safety mechanism prevents needle stick injuries in healthcare workers. Therefore, the factors mentioned earlier are expected to boost the growth of the disposable syringes market in Europe.

The market for disposable syringes in LAMEA is in its nascent phase due to a lack of buying power in the region, which leads to a shortage of specialized, extensive production facilities, inadequate health expenditure, and insufficient health coverage. The healthcare system in Brazil constitutes a significant public component, a small paid health insurance component, and a third small private component in which patients pay personally for medical services. However, governments of countries in LAMEA have increased their spending for the healthcare segment to attract key players to expand their business in this region.

Another factor that boosts the growth of the disposable syringes industry in the region is the healthcare coverage provided by Family Health Strategy (FHS), a primary healthcare model in Brazil. Furthermore, the region witnesses a high prevalence of infectious diseases like HIV and hepatitis B & C, which require injecting drugs for treatment, boosting the demand for safety syringes and driving the market's growth.

Segmental Analysis

The global disposable syringes market is segmented by product type and application.

Based on product type, the global disposable syringes market is divided into conventional disposable syringes and safety disposable syringes. 

The safety disposable syringes segment is responsible for the highest market share and is projected to grow at a CAGR of 5.1% over the forecast period. Conventional disposable syringes are available with an attached needle. These medical devices have a clear barrel for storage of drugs for delivery or collection of the blood sample from a patient. Also, these devices have a bold scale on the clear barrel, which allows accurate measurement of the contents inside the barrel. In addition, these devices have different tips, such as injections requiring a secure syringe connection to another device. The other type of tips of conventional syringes include tips used for venipunctures and aspirational fluids, allowing proximity to the skin.

Furthermore, the demand for conventional disposable syringes is rising due to awareness related to needlestick injuries. Moreover, the surge in the prevalence of chronic diseases, such as therapeutic injections, and infectious diseases, like HIV, hepatitis B, and hepatitis C, boosts the demand for conventional disposable needles. In addition, an increase in knowledge regarding using disposable syringes to reduce the spread of infectious diseases is an essential element contributing to developing conventional disposable syringes.

Safety disposable syringes are devices with a safety mechanism built into the syringe. Furthermore, the needle on this device is either attached permanently or can be detachable. Moreover, these devices work on different mechanisms of action, such as the plunger of a retractable safety disposable syringe being pulled back after use. This leads to the encasement of the used needle inside the syringe, which is then locked into place. These devices are safe to dispose of and occupy less disposable space.

Moreover, they are equipped with an integrated safety system, which is non-removable and thus reduces the system's overall size. Due to the increased usage, there has been a sharp increase in the need for safety disposable syringes. This is due to favorable government initiatives, such as promising government initiatives like the Occupational Safety and Health Administration (OSHA). This organization works toward ensuring healthcare safety practices and encourages using disposable syringes to avoid infections. Moreover, an increase in awareness among clinicians related to the benefits offered by these devices boosts market growth.

Based on application, the global disposable syringes market is segmented into immunization injections and therapeutic injections. 

The therapeutic injections segment owns the highest market share and is projected to grow at a CAGR of 4.7% during the forecast period. Therapeutic injections are used to deliver a drug to a patient's bloodstream. It requires the use of a syringe that draws drug solution from a vial to the barrel of the syringe, which is injected into the patient. Furthermore, these injections are mainly used when the drug is unstable when administered orally or through routes other than intravenous or intramuscular injections. These injections are primarily used to treat patients suffering from pain. Some of the drugs, which are administered using syringes, include antivirals and antibiotics.

Syringes are used for vaccination, aimed at providing immunization to patients. The delivery of a weakened form of virus or bacterial strain to a patient's body in the form of liquid achieves immunization. In addition, syringes used for this purpose are sterile and disposable. Furthermore, vaccination requires separate syringes and needles for every injection. In addition, there has been a surge in the use of disposable syringes for immunization injections due to different governmental guidelines recommending the use of disposable syringes for immunization. For instance, the United States-based Advisory Committee on Immunization Practices (ACIP) requires that vaccination injections be sterile and disposable. For each injection, a separate needle and syringe should be used. Such recommendations encourage using disposable syringes for immunization, which drives market growth.

Recent Developments

• December 2022- Prejex Inc., a spin-off of Prejex GMBH of Germany, agreed to manufacture needleless injections with Polybond, led by Adit Rathi of Rathi Group. This agreement has facilitated the relocation of the German company's manufacturing capabilities from Berlin to Pune for global distribution.

• January 2023- Stevanato Group S.p.A. collaborated with Transcoject GmbH, a medical device and pharma packaging solutions provider. Stevanato Group will be able to add cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) pre-fillable syringes to its existing offering of value-added supply chain solutions for customers.